Molecular Partners AG (MOLN) stock
MOLNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.86+0.16 (+5.98%)
Close on Nov 17, 2026Market cap $115.47MP/E –Yield –
Molecular Partners net income
Net income is the profit left for shareholders after every expense, interest and tax.
No net income figures for Molecular Partners
Molecular Partners has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?